the guidelines on antibiotic application in gynaecological oncology
Clicks: 289
ID: 260216
2005
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
289 views
41 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #9 of 27 articles by views in green energy and technology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Standardized and effective antibiotic therapy regimes in gynecology need to be based on the protocols prescribed by acknowledged specialists. Antibiotic therapy can have either prophylactic or therapeutic purposes. Antibiotics of the narrowest possible spectrum are recommended, as well as their shortest while most effective application. The choice is firstly determined by the effectiveness and secondly by the price. Preventive use of antibiotics and the doses in gynecological surgery depend on the type of surgery. If antibiotic therapy is prophylactic, first generation cephalosporin should always be used. Irrational antibiotic therapy, especially when using third generation cephalosporin, can result in strains of resistant hospital bacteria.
| Reference Key |
ljiljana2005archivethe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Mladenović-Segedi Ljiljana;Segedi Dimitrije;Radaković Jelena;Ilić Maja;Kojić Slobodan |
| Journal | green energy and technology |
| Year | 2005 |
| DOI |
10.2298/AOO0502083M
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.